The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Characterizing the genomic landscape of POLE/POLD1-mutated colorectal adenocarcinoma.
 
Tucker Coston
No Relationships to Disclose
 
Elizabeth Mauer
Employment - Tempus
Stock and Other Ownership Interests - Tempus
Research Funding - Tempus
Travel, Accommodations, Expenses - Tempus
 
Jeremy Clifton Jones
No Relationships to Disclose
 
Joleen M. Hubbard
Consulting or Advisory Role - Bayer (Inst); BeiGene (Inst); Incyte (Inst); Incyte (Inst); Merck; Taiho Oncology (Inst)
Research Funding - Bayer (Inst); G1 Therapeutics (Inst); Incyte (Inst); Merck (Inst); Pfizer (Inst); Pionyr (Inst); Seagen (Inst); Senhwa Biosciences (Inst); Taiho Pharmaceutical (Inst); Translational Research in Oncology (Inst); Treos Bio (Inst); Trovagene (Inst)
 
Tanios S. Bekaii-Saab
Consulting or Advisory Role - Abbvie; Amgen (Inst); Arcus Biosciences (Inst); AstraZeneca; Bayer (Inst); BeiGene; Boehringer Ingelheim; Celularity; Daiichi Sankyo/UCB Japan; Deciphera; Eisai; Eisai; Exact Sciences; Foundation Medicine; Foundation Medicine; Illumina; Immuneering; Incyte (Inst); Ipsen (Inst); Janssen; Kanaph Therapeutics; Lilly (Inst); Natera; Pfizer (Inst); Roche/Genentech (Inst); Seagen (Inst); SOBI; Stemline Therapeutics; Treos Bio
Patents, Royalties, Other Intellectual Property - Patent WO/2018/183488; Patent WO/2019/055687
Other Relationship - 1Globe Health Institute; AstraZeneca; Exelixis; FibroGen; Imugene; Lilly; Merck (Inst); Pancreatic Cancer Action Network; Replimune; Sun Biopharma; Suzhou Kintor Pharmaceuticals; UpToDate; Xilis
 
Melissa Conrad Stoppler
Employment - Exact Sciences; Gilead Sciences (I); Roche/Genentech (I); Roche/Genentech (I); Tempus
Stock and Other Ownership Interests - Exact Sciences; Roche/Genentech (I); Tempus
 
Jason S. Starr
Consulting or Advisory Role - Advanced Accelerator Applications; Ipsen; Natera; Pfizer; Taiho Oncology; Tersera
Research Funding - Incyte (Inst); Leap Therapeutics; Macrogenics (Inst); Merus (Inst); Molecular Templates (Inst); Rafael Pharmaceuticals (Inst); Vedanta Biosciences (Inst)